Dorsey & Whitney advised Shuttle Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners in the offering. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) announced the pricing...
Shuttle Pharmaceuticals’ $4.5 Million Common Stock Offering
CNS Pharmaceuticals’ $3 Million Common Stock Offering
ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. CNS Pharmaceuticals, Inc. closed the $3 million registered direct offering...
XORTX Therapeutics’ $1.5 Million Direct Offering and Concurrent Private Placement
Sullivan & Worcester represented A.G.P./Alliance Global Partners in the transaction. XORTX Therapeutics has entered into securities purchase agreements with institutional investors for the purchase and sale...
Cibus’ $12 Million Common Stock Offering
Jones Day represented Cibus, while Sullivan & Worcester represented ROTH Capital Partners and A.G.P./Alliance Global Partners on the offering. Cibus, Inc. (Nasdaq: CBUS) announced the public...
BioCardia’s $7.2 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised BioCardia, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. BioCardia, Inc. (Nasdaq: BCDA) completed its $7.2 million...
Pharma Two B’s Merger With Hepion Pharmaceuticals
Sheppard, Mullin, Richter & Hampton is acting as U.S. legal advisor to Hepion and Lipa Meir & Co. is acting as Israeli legal advisor to Hepion....
Gorilla Technology Group’s $12 Million Shares Offering
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Gorilla Technology Group, Inc. (Nasdaq: GRRR) executed a $12 million offering of ordinary shares and warrants....
Soligenix’s $4.75 Million Common Stock Offering
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Soligenix, Inc. (Nasdaq: SNGX) $4.75 million public offering of common stock and warrants, consisting of 11,875,000...
Matinas BioPharma’s $10 Million Common Stock Offering
Lowenstein Sandler represented Matinas BioPharma, while Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) entered into securities purchase...
SELLAS Life Sciences Group’s $20 Million Common Stock Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo represented SELLAS, while Sullivan & Worcester was placement agent’s counsel for A.G.P./Alliance Global Partners in the transaction. SELLAS Life...
Gorilla Technology Group’s $10 Million Shares Offering
Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Gorilla Technology Group Inc. executed its $10 million public offering of preferred shares and warrants. A.G.P./Alliance...
Chromocell Therapeutics Corporation’s $6.6 Million Initial Public Offering
Sullivan & Worcester represented Chromocell Therapeutics Corporation, while Manatt, Phelps & Phillips represented A.G.P./ Alliance Global Partners in the transaction. Chromocell Therapeutics Corporation executed their $6.6...